The Value of Biosimilars Action Brief (July 2018)

Biosimilar drugs and their potential benefits to employers and employees is showing great promise – in terms of dramatically lowering costs and improving access and incomes. The Value of Biosimilars Action Brief – 07 2018
This content is only available to members. Learn more about membership here or login.